Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2015 1
2019 2
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer.
Michel LL, von Au A, Mavratzas A, Smetanay K, Schütz F, Schneeweiss A. Michel LL, et al. Target Oncol. 2020 Aug;15(4):415-428. doi: 10.1007/s11523-020-00730-0. Target Oncol. 2020. PMID: 32514907 Review.
Prediction of local recurrence risk after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the MD Anderson Prognostic Index.
Michel LL, Sommer L, González Silos R, Lorenzo Bermejo J, von Au A, Seitz J, Hennigs A, Smetanay K, Golatta M, Heil J, Schütz F, Sohn C, Schneeweiss A, Marmé F. Michel LL, et al. PLoS One. 2019 Jan 31;14(1):e0211337. doi: 10.1371/journal.pone.0211337. eCollection 2019. PLoS One. 2019. PMID: 30703111 Free PMC article.
Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: clinical utility of the CPS + EG score.
Michel LL, Sommer L, González Silos R, Lorenzo Bermejo J, von Au A, Seitz J, Hennigs A, Smetanay K, Golatta M, Heil J, Schütz F, Sohn C, Schneeweiss A, Marmé F. Michel LL, et al. Breast Cancer Res Treat. 2019 Sep;177(2):437-446. doi: 10.1007/s10549-019-05314-9. Epub 2019 Jun 24. Breast Cancer Res Treat. 2019. PMID: 31236813
T-DM1 as a New Treatment Option for Patients with Metastatic HER2-positive Breast Cancer in Clinical Practice.
Michel LL, Bermejo JL, Gondos A, Marmé F, Schneeweiss A. Michel LL, et al. Anticancer Res. 2015 Sep;35(9):5085-90. Anticancer Res. 2015. PMID: 26254411
Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases.
Berghoff AS, Breckwoldt MO, Riedemann L, Karimian-Jazi K, Loew S, Schlieter F, Furtner J, Cinci M, Thomas M, Strowitzki MJ, Marmé F, Michel LL, Schmidt T, Jäger D, Bendszus M, Preusser M, Wick W, Winkler F. Berghoff AS, et al. Among authors: michel ll. Neurooncol Adv. 2020 Mar 16;2(1):vdaa038. doi: 10.1093/noajnl/vdaa038. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32642693 Free PMC article.
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab.
Michel LL, Hartkopf AD, Fasching PA, Kolberg HC, Hadji P, Tesch H, Häberle L, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Belleville E, Volz B, Huebner H, Wimberger P, Hielscher C, Mundhenke C, Kurbacher C, Wuerstlein R, Untch M, Overkamp F, Huober J, Janni W, Taran FA, Lux MP, Wallwiener D, Brucker SY, Schneeweiss A, Fehm TN. Michel LL, et al. Cancers (Basel). 2020 Oct 17;12(10):3021. doi: 10.3390/cancers12103021. Cancers (Basel). 2020. PMID: 33080911 Free PMC article.
Embolization of a large inferior vena cava aneurysm in a child.
Michel LL, Alomari AI. Michel LL, et al. J Vasc Interv Radiol. 2008 Oct;19(10):1509-12. doi: 10.1016/j.jvir.2008.07.012. Epub 2008 Aug 27. J Vasc Interv Radiol. 2008. PMID: 18755605
Feedback